|Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide|
DE Brenneman, GL Westbrook, SP Fitzgerald, DL Ennist, KL Elkins, ...
Nature 335 (6191), 639-642, 1988
|An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.|
PH Driggers, DL Ennist, SL Gleason, WH Mak, MS Marks, BZ Levi, ...
Proceedings of the National Academy of Sciences 87 (10), 3743-3747, 1990
|Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus|
JR Flanagan, KG Becker, DL Ennist, SL Gleason, PH Driggers, BZ Levi, ...
Molecular and cellular biology 12 (1), 38-44, 1992
|The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds|
Y Kanno, CA Kozak, C Schindler, PH Driggers, DL Ennist, SL Gleason, ...
Molecular and cellular biology 13 (7), 3951-3963, 1993
|Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses|
K Otake, DL Ennist, K Harrod, BC Trapnell
Human gene therapy 9 (15), 2207-2222, 1998
|CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor–armed oncolytic adenovirus for the treatment of bladder cancer|
N Ramesh, Y Ge, DL Ennist, M Zhu, M Mina, S Ganesh, PS Reddy, DC Yu
Clinical cancer research 12 (1), 305-313, 2006
|Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir|
NC Munshi, R Govindarajan, R Drake, LM Ding, R Iyer, R Saylors, ...
Blood, The Journal of the American Society of Hematology 89 (4), 1334-1340, 1997
|In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF|
JA Bristol, M Zhu, H Ji, M Mina, Y Xie, L Clarke, S Forry-Schaudies, ...
Molecular Therapy 7 (6), 755-764, 2003
|Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells|
Z Long, LP Li, T Grooms, C Lockey, K Nader, I Mychkovsky, S Mueller, ...
Human gene therapy 9 (8), 1165-1172, 1998
|Modulation of immune responses by surface polysaccharides of Candida albicans|
J Domer, K Elkins, D Ennist, P Baker
Reviews of infectious diseases, S419-S422, 1988
|Rapid method for identification of macrophages in suspension by acid alpha-naphthyl acetate esterase activity.|
DL Ennist, KH Jones
Journal of Histochemistry & Cytochemistry 31 (7), 960-963, 1983
|Predicting disease progression in amyotrophic lateral sclerosis|
AA Taylor, C Fournier, M Polak, L Wang, N Zach, M Keymer, JD Glass, ...
Annals of Clinical and Translational Neurology 3 (11), 866-875, 2016
|Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM …|
DL Ennist, KH Jones, RL St Pierre, RL Whisler
The Journal of Immunology 136 (1), 99-105, 1986
|Being PRO-ACTive: what can a clinical trial database reveal about ALS?|
N Zach, DL Ennist, AA Taylor, H Alon, A Sherman, R Kueffner, J Walker, ...
Neurotherapeutics 12 (2), 417-423, 2015
|Novel oncolytic adenoviral vectors|
C Cheng, L Clarke, S Connelly, D Ennist, S Forry-Schaudies, M Gorziglia, ...
US Patent App. 10/081,969, 2003
|In Vivo Delivery of Interleukin-4 by a Recombinant Vaccinia Virus Prevents Tumor Development in Mice|
KL Elkins, DL Ennist, RK Winegar, JP Weir
Human gene therapy 5 (7), 809-820, 1994
|Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses|
M Zhu, JA Bristol, Y Xie, M Mina, H Ji, S Forry-Schaudies, DL Ennist
Journal of virology 79 (9), 5455-5465, 2005
|Gene therapy for lung disease|
Trends in pharmacological sciences 20 (6), 260-266, 1999
|Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL|
KD Burroughs, DB Kayda, K Sakhuja, Y Hudson, J Jakubczak, JA Bristol, ...
Cancer gene therapy 11 (2), 92-102, 2004
|Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein|
JE Domer, KL Elkins, DL Ennist, PW Stashak, RE Garner, PJ Baker
Infection and immunity 55 (11), 2619-2624, 1987